Glialign
London, United Kingdom· Est.
Develops therapies targeting glial cells for neurological disorders and brain injuries.
Private Company
Total funding raised: $3.8M
About
Develops therapies targeting glial cells for neurological disorders and brain injuries.
Tissue Engineering
Funding History
1Total raised:$3.8M
Seed$3.8M